BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23316799)

  • 1. Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes.
    Wender-Ozegowska E; Zawiejska A; Ozegowska K; Wroblewska-Seniuk K; Iciek R; Mantaj U; Olejniczak D; Brazert J
    Aust N Z J Obstet Gynaecol; 2013 Apr; 53(2):130-5. PubMed ID: 23316799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
    Abell SK; Suen M; Pease A; Boyle JA; Soldatos G; Regan J; Wallace EM; Teede HJ
    Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes.
    Gong Y; Wei T; Liu Y; Wang J; Yan J; Yang D; Luo S; Weng J; Zheng X
    J Diabetes; 2024 May; 16(5):e13558. PubMed ID: 38664886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
    Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K
    Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
    Chico A; Saigi I; García-Patterson A; Santos MD; Adelantado JM; Ginovart G; de Leiva A; Corcoy R
    Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes.
    Kekäläinen P; Juuti M; Walle T; Laatikainen T
    Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with Type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection.
    Hauffe F; Schaefer-Graf UM; Fauzan R; Schohe AL; Scholle D; Sedlacek L; Scherer KA; Klapp C; Ramsauer B; Henrich W; Schlembach D; Abou-Dakn M
    Diabet Med; 2019 Feb; 36(2):158-166. PubMed ID: 30698863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis.
    Ranasinghe PD; Maruthur NM; Nicholson WK; Yeh HC; Brown T; Suh Y; Wilson LM; Nannes EB; Berger Z; Bass EB; Golden SH
    J Womens Health (Larchmt); 2015 Mar; 24(3):237-49. PubMed ID: 25713996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
    Farrar D; Tuffnell DJ; West J; West HM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD005542. PubMed ID: 27272351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
    Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
    Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.
    Cyganek K; Hebda-Szydlo A; Katra B; Skupien J; Klupa T; Janas I; Kaim I; Sieradzki J; Reron A; Malecki MT
    Diabetes Technol Ther; 2010 Jan; 12(1):41-7. PubMed ID: 20082584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion and multiple dose insulin injections in Type 1 diabetic pregnant women: a case-control study.
    Volpe L; Pancani F; Aragona M; Lencioni C; Battini L; Ghio A; Resi V; Bertolotto A; Del Prato S; Di Cianni G
    Gynecol Endocrinol; 2010 Mar; 26(3):193-6. PubMed ID: 19728190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin for the Management of Type 1 Diabetes Mellitus in Pregnancy: Association with Neonatal Chemical Hypoglycemia.
    Sargent JA; Roeder HA; Ward KK; Moore TR; Ramos GA
    Am J Perinatol; 2015 Dec; 32(14):1324-30. PubMed ID: 26461928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.
    Rys PM; Ludwig-Slomczynska AH; Cyganek K; Malecki MT
    Eur J Endocrinol; 2018 May; 178(5):545-563. PubMed ID: 29545258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
    Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
    Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Subcutaneous Infusion Versus Multiple Daily Injections of Insulin for Pregestational Diabetes in Pregnancy: A Systematic Review and Meta-Analysis.
    Fisher SA; Huang J; DuBord AY; Xu NY; Beestrum M; Niznik C; Yeung AM; Nguyen KT; Klonoff DC; Yee LM
    J Diabetes Sci Technol; 2023 Sep; 17(5):1337-1363. PubMed ID: 37542367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
    Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
    Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy.
    Neff KJ; Forde R; Gavin C; Byrne MM; Firth RG; Daly S; McAuliffe FM; Foley M; Coffey M; Coulter-Smith S; Kinsley BT
    Ir J Med Sci; 2014 Sep; 183(3):397-403. PubMed ID: 24142539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal-fetal outcomes of pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections during pregnancy - A Brazilian health care referral center cohort study.
    Ogassavara J; Dualib PM; Mattar R; Dib SA; de Almeida-Pititto B
    Arch Endocrinol Metab; 2023 Jun; 67(6):e220483. PubMed ID: 37364140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.